Vedanta Enrolls First Phase 3 VE303 C. Diff Prevention Patient
21 May 2024 //
BUSINESSWIRE
PureTech`s Vedanta Enrolls First Phase 3 VE303 C. Diff Prevention Patient
21 May 2024 //
BUSINESSWIRE
21 May 2024 //
BUSINESSWIRE
21 May 2024 //
BUSINESSWIRE